SAN || News

Low-risk actinic keratosis? No such thing

Posted on: 13/11/2014 - 19:13

AMSTERDAM – The majority of cutaneous infiltrating squamous cell carcinomas arise via direct transformation of grade 1 actinic keratoses – that is, differentiated dysplasia of the basal one-third of...

Field of Interest: Dermatology

Type: News Item

Skin cancer treatment costs skyrocket over past decade

Posted on: 12/11/2014 - 14:13

The average annual cost for skin cancer treatment more than doubled from 2002 to 2011, a report from the Centers for Disease Control and Prevention found. From 2002 to 2006, the average annual skin...

Field of Interest: Dermatology

Type: News Item

Oral curcumin shown effective in psoriasis

Posted on: 10/11/2014 - 15:35

AMSTERDAM – Oral curcumin proved safe and effective as adjunctive therapy in patients on topical corticosteroids for mild to moderate psoriasis vulgaris in a 12-week, randomized, placebo-controlled...

Field of Interest: Dermatology

Type: News Item

Apremilast succeeds against nail, scalp, palmoplantar psoriasis

Posted on: 03/11/2014 - 19:36

LAS VEGAS – A twice-daily 30-mg dose of apremilast significantly improved moderate to severe nail, scalp, and palmoplantar psoriasis, compared with placebo, based on data from 411 adults in the...

Field of Interest: Dermatology

Type: News Item

Topical steroid might improve mucosal integrity in eosinophilic esophagitis

Posted on: 01/11/2014 - 04:01

Topical steroid therapy improved some indicators of mucosal integrity in patients with eosinophilic esophagitis, but proton pump inhibitor therapy did not, according to two studies reported in the...

Field of Interest: Gastroentero...

Type: News Item

Psoriasis patients’ QOL improved with calcipotriene/betamethasone

Posted on: 31/10/2014 - 17:46

LAS VEGAS – Adults with localized psoriasis reported significant improvement in quality of life after 2 and 8 weeks of treatment with a combination topical suspension, based on data from 147 adults....

Field of Interest: Dermatology

Type: News Item

Novel psoriasis biologic wows with jaw-dropping results

Posted on: 31/10/2014 - 16:44

AMSTERDAM– The spectacular long-term efficacy achieved with a novel biologic agent for psoriasis in a first-in-humans, proof-of-concept study has raised the prospect of clinical outcomes continuing...

Field of Interest: Dermatology

Type: News Item

VIDEO: A practical protocol for monitoring discoid lupus

Posted on: 23/10/2014 - 22:06

NEWPORT BEACH, CALIF.– Patients with discoid lupus should be checked routinely for systemic disease, but complete autoantibody studies aren’t necessary for those patients with a prior work-up and a...

Field of Interest: Dermatology

Type: News Item

FDA panel unanimously supports secukinumab approval for psoriasis

Posted on: 20/10/2014 - 23:15

SILVER SPRING, MD. – The human monoclonal antibody secukinumab is expected to be the first biologic that targets interleukin-17A to be approved by the agency for treating psoriasis, with a Food and...

Field of Interest: Dermatology

Type: News Item

Secukinumab showed sustained efficacy in psoriasis

Posted on: 19/10/2014 - 17:57

AMSTERDAM – The investigational biologic agent secukinumab continued to show strong efficacy through 52 weeks of treatment in a new secondary analysis of the pivotal phase III ERASURE trial. For...

Field of Interest: Dermatology

Type: News Item

« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters